NCT00388531View on ClinicalTrials.gov

Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2011

Study Completion Date

June 30, 2011

Conditions
Lymphoblastic LeukemiaLymphoma
Interventions
DRUG

Depocyte®

Depocyte® is a cytostatic drug

Trial Locations (9)

Unknown

"Hospital Santa Creu i Sant Pau", Barcelona

Hospital Clínico y Provincial de Barcelona, Barcelona

Hospital Germans Trias i Pujol, Barcelona

Hospital Clínico San Carlos de Madrid, Madrid

Hospital Doce de Octubre, Madrid

. Hospital Clínico Universitario Virgen de la Victoria, Málaga

Hospital Universitario Virgen del Rocío, Seville

Hospital La Fe, Valencia

Hospital Clínico Universitario de Salamanca, Salamanca

All Listed Sponsors
lead

PETHEMA Foundation

OTHER

NCT00388531 - Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma | Biotech Hunter | Biotech Hunter